PERSISTENT2024-01-012024-03-31 PERSISTENT2024-01-012024-03-31 PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses02Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses03Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses04Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses05Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses06Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses07Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses08Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses09Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneOperatingExpenses10Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses02Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses03Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses04Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses05Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses06Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses07Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses08Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses09Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourOperatingExpenses10Member PERSISTENT2024-03-31 PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue02Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue03Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue01Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue02Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue03Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults02Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults03Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults01Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults02Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults03Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets02Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets03Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2024-03-31in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533179 PERSISTENT NOTLISTED Persistent Systems Limited Equity 2023-04-01 2024-03-31 2024-04-21 2024-04-03 INR Millions Yearly 19:10:00 19:30:00 2024-04-21 2024-04-21 true Cash Flow Indirect Declaration of unmodified opinion Multi segment 2024-01-01 2024-03-31 Audited Consolidated 25905260000.00 307830000.00 26213090000.00 0.00 0.00 0.00 18935570000.00 97350000.00 799170000.00 2426080000.00 22258170000.00 3954920000.00 0.00 3954920000.00 757790000.00 43920000.00 801710000.00 0.00 3153210000.00 0.00 0.00 0.00 0.00 3153210000.00 -70200000.00 3083010000.00 3153210000.00 0.00 -70200000.00 0.00 770250000.00 5 20.73 20.48 0.00 0.00 20.73 20.48 0.00 0.02 0.00 1.The audited condensed interim consolidated financial statements as of March 31, 2024, have been taken on record by the Board at its meeting held on April 21, 2024 as recommended by the Audit Committee at its meeting held on April 20, 2024. The statutory auditors have expressed an unmodified audit opinion. The information presented above is extracted from the audited condensed interim consolidated financial statements. 2.The above results have been prepared from the condensed interim consolidated financial statements, which are prepared in accordance with Ind AS, the provisions of the Companies Act, 2013 as applicable and guidelines issued by the SEBI. The Ind AS are prescribed under Sec 133 of the Companies Act read with relevant Rule. All amounts included in the consolidated financial results (including notes) are reported in in INR Millions except share and per share data, unless otherwise stated. 3.The Board at its meeting held on Jan 20, 2024, approved the issuance of 1,000,000 equity shares of INR 10 each to the ESOP Trust in multiple tranches during the calendar year 2024 and authorized the SRC Committee to allot the said Equity Shares to the ESOP Trust. Accordingly, the first tranche of 100,000 equity shares of INR 10 each was allotted to the ESOP Trust on Feb 1, 2024, at a consideration of INR 2,133 per equity share aggregating to the total consideration of INR 213.3 million. Consequent to this, the number of shares of paid-up share capital of the Company was increased from 76,925,000 equity shares to 77,025,000 equity shares of INR 10 each and the listing process of aforesaid shares was completed w.e.f Mar 1, 2024. 4.Persistent Systems S.R.L, Italy has been dissolved w.e.f Feb 26, 2024. 5.The Board at its meeting held on Jan 20, 2024, approved the Scheme of Merger of Capiot Software Private Limited into Persistent Systems Limited, and accordingly, an application of Merger has been filed with the NCLT on Mar 22, 2024. 6.The Members of the Company approved the Split of 1 fully paid up equity share of INR 10 each into 2 fully paid up equity shares of INR 5 each through a postal ballot with a requisite majority and the voting results were declared on March 11, 2024. Record Date for Split was Apr 1, 2024. Consequent to this, the authorized share capital comprises 400,000,000 equity shares having a FV of INR 5 each aggregating to INR 2,000,000,000, and the paid-up capital comprises 154,050,000 equity shares having a FV of INR 5 each aggregating to INR 770,250,000. 7.The Board at its meeting held on Jan 20, 2024, approved the payment of an Interim Dividend of INR 32 per Equity Share of INR 10 each for FY 2023-24. Accordingly, an amount of INR 2,461,573,386.75 was paid as an Interim Dividend out of the total dividend amount of INR 2,461,600,000.00. The remaining amount of INR 26,613.25 is unclaimed and the Company will make due efforts to pay the same to the respective Shareholders. 8.The SPA for the transfer of the 100% shareholding of Persistent Systems UK Limited to Persistent Systems Limited was executed on Mar 19, 2024. 9.The BTA has been executed for the transfer of the business of the UK Branch of the Company to Persistent Systems UK Limited effective from Apr 1, 2024. 10.The Company has applied for incorporation of a Company (Not for Profit) under Section 8 of the Companies Act, 2013 on April 9, 2024, with the MCA 11.The Board at its meeting on Apr 21, 2024, recommended a Final Dividend of INR 10 per Equity Share of INR 5 each for FY 2023-24. This Final Dividend is subject to the approval of the Members at the ensuing 34th AGM of the Company. 12.In accordance with para 4 of notified Ind AS-108 “Operating Segments”, the Company has disclosed segment information only on the basis of consolidated financial results. 13.The investors are requested to visit the following website of the Company and stock exchanges for further details. Multi segment 2023-04-01 2024-03-31 Audited Consolidated 98215870000.00 1280200000.00 99496070000.00 0.00 0.00 0.00 71102400000.00 467270000.00 3093730000.00 10356610000.00 85020010000.00 14476060000.00 0.00 14476060000.00 3752840000.00 -211690000.00 3541150000.00 0.00 10934910000.00 0.00 0.00 0.00 0.00 10934910000.00 57430000.00 10992340000.00 10934910000.00 0.00 57430000.00 0.00 770250000.00 5 0.00 72.44 71.07 0.00 0.00 72.44 71.07 0.00 0.02 0.00 Advertisement, conference and sponsorship fees 23610000.00 Allowance for expected credit loss (net) -47870000.00 Legal and professional fees 260200000.00 Miscellaneous expenses -113130000.00 Other Expenses 205550000.00 Purchase of software licenses 1509560000.00 Recruitment expenses 70060000.00 Rent 28190000.00 Training and seminars 49030000.00 Travelling and conveyance 440880000.00 Advertisement, conference and sponsorship fees 185090000.00 Allowance for expected credit loss (net) 103570000.00 Legal and professional fees 1063960000.00 Miscellaneous expenses 538070000.00 Other Expenses 757870000.00 Purchase of software licenses 5608160000.00 Recruitment expenses 250380000.00 Rent 145930000.00 Training and seminars 169860000.00 Travelling and conveyance 1533720000.00 0.00 4420030000.00 335260000.00 0.00 10912560000.00 6882130000.00 0.00 0.00 0.00 5539140000.00 730180000.00 0.00 525310000.00 6794630000.00 1359640000.00 1413030000.00 32117280000.00 0.00 2726540000.00 16761130000.00 6625150000.00 3603710000.00 0.00 6621830000.00 36338360000.00 387050000.00 4893490000.00 41618900000.00 0.00 0.00 73736180000.00 770250000.00 48806820000.00 49577070000.00 49577070000.00 99150000.00 0.00 1608090000.00 1707240000.00 546960000.00 18760000.00 0.00 44440000.00 2317400000.00 1974040000.00 8138620000.00 4548280000.00 14660940000.00 3302820000.00 3330660000.00 547290000.00 0.00 21841710000.00 0.00 0.00 24159110000.00 73736180000.00 Banking, Financial Services and Insurance (BFSI) 7958670000.00 Healthcare & Life Sciences 6278120000.00 Software, Hi-Tech and Emerging Industries 11668470000.00 Banking, Financial Services and Insurance (BFSI) 31385580000.00 Healthcare & Life Sciences 20880320000.00 Software, Hi-Tech and Emerging Industries 45949970000.00 25905260000.00 98215870000.00 0.00 0.00 25905260000.00 98215870000.00 Banking, Financial Services and Insurance (BFSI) 2768320000.00 Healthcare & Life Sciences 2268800000.00 Software, Hi-Tech and Emerging Industries 3016310000.00 Banking, Financial Services and Insurance (BFSI) 11523860000.00 Healthcare & Life Sciences 8671220000.00 Software, Hi-Tech and Emerging Industries 11804660000.00 8053430000.00 31999740000.00 97350000.00 467270000.00 4001160000.00 17056410000.00 3954920000.00 14476060000.00 Banking, Financial Services and Insurance (BFSI) 6128360000.00 Healthcare & Life Sciences 4236240000.00 Software, Hi-Tech and Emerging Industries 13648050000.00 24012650000.00 49723530000.00 73736180000.00 Banking, Financial Services and Insurance (BFSI) 0.00 Healthcare & Life Sciences 0.00 Software, Hi-Tech and Emerging Industries 0.00 0.00 73736180000.00 73736180000.00 467270000.00 0.00 -1810640000.00 0.00 -1475230000.00 -256220000.00 0.00 -1751220000.00 0.00 4386280000.00 0.00 0.00 0.00 3093730000.00 20580000.00 -1144650000.00 0.00 0.00 0.00 27270000.00 0.00 562450000.00 1091750000.00 -289110000.00 0.00 0.00 0.00 -646610000.00 0.00 1150750000.00 15626810000.00 0.00 0.00 0.00 3413740000.00 0.00 12213070000.00 0.00 2073640000.00 0.00 0.00 0.00 0.00 0.00 0.00 48650000.00 2839160000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 169470000.00 0.00 -4694680000.00 0.00 0.00 1607800000.00 0.00 0.00 0.00 0.00 0.00 0.00 2233720000.00 0.00 760180000.00 4083620000.00 467310000.00 0.00 349830000.00 -5587200000.00 1931190000.00 23840000.00 1955030000.00 4670120000.00 6625150000.00 0.00 0.00 Effective portion of cash flow hedge (net of tax) and Remeasurements of the defined benefit liabilities / asset -70200000.00 Exchange differences in translating the financial statements of foreign operations 0.00 Effective portion of cash flow hedge (net of tax) and Remeasurements of the defined benefit liabilities / asset 57430000.00 Exchange differences in translating the financial statements of foreign operations 0.00 -70200000.00 57430000.00 0.00 0.00